← Back to Clinical Trials
Recruiting NCT04342429
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Trial Parameters
Condition Small-cell Lung Cancer
Sponsor Emory University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-03-19
Completion 2026-05-27
Interventions
Proton-beam Therapy for Small Cell Lung Cancer
Brief Summary
To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
Eligibility Criteria
Inclusion Criteria: * Pathologically confirmed small cell lung cancer, limited or extensive stage. * Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist. * Age 18 or greater Exclusion Criteria: * Prior radiation therapy which would provide significant dose overlap with the planned target volume(s) * Pregnancy
Related Trials
NCT04342429
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
View Trial →
NCT07026669
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in
View Trial →
NCT06467786
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
View Trial →